2013China Medicine and PharmacyRequires access

Clinical value of procalcitonin for therapeutic effect observation and early diagnosis in eldly patients with pneumonia

Qin Mao

Open publisher page 0 citations

Abstract

Objective To explore the clinical value of Procalcitonin(PCT) for early diagnosis and therapeutic effect observation of elderly patients with pneumonia. Methods A total of 86 elderly patients were divided into 2 groups (pneumonia group and non-pneumonia group).The white blood cells contents,serum procalcitonin levels,blood culture,sputum culture were determined as well as the chest X-ray or CT was examined. Results The procalcitonin levels in pneumonia group were significantly higher than those in control group,while white blood cell levels were not significant difference between two groups. The significant different of the positive rate of PCT,blood cultures,sputum culture was observed in pneumonia group. Conclusion Serum procalcitonin is valuable for early diagnosis and therapeutic efficacy in elderly patients with pneumonia.

About this research paper

What this paper is about

Objective To explore the clinical value of Procalcitonin(PCT) for early diagnosis and therapeutic effect observation of elderly patients with pneumonia. Methods A total of 86 elderly patients were divided into 2 groups (pneumonia group and non-pneumonia group).The white blood cells contents,serum procalcitonin levels,blood culture,sputum culture were determined as well as the chest X-ray or CT was examined. Results The procalcitonin levels in pneumonia group were significantly higher than those in control group,while white blood cell levels were not significant difference between two groups. The significant different of the positive rate of PCT,blood cultures,sputum culture was observed in pneumonia group. Conclusion Serum procalcitonin is valuable for early diagnosis and therapeutic efficacy in elderly patients with pneumonia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical value of Procalcitonin(PCT) for early diagnosis and therapeutic effect observation of elderly patients with pneumonia. Methods A total of 86 elderly patients were divided into 2 groups (pneumonia group and non-pneumonia group).The white blood cells contents,serum procalcitonin levels,blood culture,sputum culture were determined as well as the chest X-ray or CT was examined. Results The procalcitonin levels in pneumonia group were significantly higher than those in control group,while white blood cell levels were not significant difference between two groups. The significant different of the positive rate of PCT,blood cultures,sputum culture was observed in pneumonia group. Conclusion Serum procalcitonin is valuable for early diagnosis and therapeutic efficacy in elderly patients with pneumonia.

Key concepts: Procalcitonin, Medicine, Pneumonia, Sputum, Sputum culture, White blood cell, Internal medicine, Blood culture

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical value of procalcitonin for therapeutic effect observation and early diagnosis in eldly patients with pneumonia — Research Paper | ScholarLens